Investor Notes - Phillip Securities (HK) Ltd

27 Jun, 2025 (Friday)

GANFENG LITHIUM(1772)
Analysis：
Ganfeng Lithium leverages its upstream lithium resource supply and full industrial chain advantages, with its lithium battery business covering five major categories and over 20 product types, including solid-state lithium batteries, power batteries, consumer batteries, polymer lithium batteries, storage batteries, and energy storage systems. These products range from milliampere-hour to hundreds of ampere-hour capacities and incorporate solid-state technology, aiding automakers, battery manufacturers, and consumer brands in achieving energy transitions.Solid-state batteries are a new energy storage technology with a working principle similar to liquid lithium-ion batteries. The main materials for solid-state lithium-ion batteries include cathode materials, anode materials, and solid-state electrolytes. The core innovation lies in replacing the liquid electrolyte and separator in traditional batteries with a solid-state electrolyte, eliminating or minimizing the use of separators and liquid electrolytes. Compared to conventional lithium-ion batteries, solid-state batteries offer higher energy density (storing more energy per unit volume/weight), faster charging speeds, longer lifespans, and enhanced safety (avoiding risks of liquid electrolyte leakage or combustion). However, this technology currently faces challenges such as high electrolyte material costs, significant interface impedance, and immature large-scale production processes, making it a key development direction for next-generation battery technology.Ganfeng is the only company in the industry with integrated upstream and downstream capabilities in solid-state batteries. It has developed research and production capabilities across critical solid-state battery components, including sulfide electrolytes and raw materials, oxide electrolytes, lithium metal anodes, battery cells, and battery systems. The group achieved mass production of battery-grade lithium sulfide in 2022 and further expanded its production line in 2024. Ganfeng`s lithium sulfide products have a purity of ≥99.9%, characterized by high purity, low impurity content, and excellent consistency, meeting the technical requirements for highly conductive solid-state electrolyte materials. The company currently supplies over 20 downstream customers.In terms of solid-state battery anodes, Ganfeng`s ultra-thin lithium strips have reached mass production capability, offering tailored solutions for cycle performance, processability, and electrochemical stability. The group has achieved mass production of ultra-wide (300mm) ultra-thin lithium strips, with lithium foil in copper-lithium composite strips as thin as 3 micrometers. Lithium metal batteries using ultra-thin lithium strips or copper-lithium composite strips as anodes are considered the most promising battery type, with Ganfeng`s solid-state batteries equipped with lithium metal anodes achieving energy densities exceeding 500Wh/kg.Regarding solid-state battery applications, amidst the booming low-altitude economy, Ganfeng has actively expanded into this sector, successfully developing a range of high-energy-density, high-power flight power cells and power system products. These offer diverse solutions tailored to various flight scenarios and requirements, with cell energy densities ranging from 320Wh/kg to 500Wh/kg and exceptional performance at continuous discharge rates above 5C. These high-performance, reliable products meet customer needs and support the rise of the low-altitude economy. Ganfeng Lithium Battery has partnered with well-known drone and eVTOL companies in the high-specific-energy battery sector, co-developing power systems to meet market demands, with plans to deliver the first batch of samples in 2025. (I do not hold the above stock)
Strategy：
Buy-in Price: $22.10, Target Price: $24.50, Cut Loss Price: $21.00

ABBISKO-B(2256)
Analysis：
The Company is focused on the research and development of innovative drugs for targeted and tumor immunotherapy. Since its establishment in 2016, it has developed rapidly. In August 2019, the Company announced that its independently developed highly specific CSF-1R small molecule inhibitor, pimitinib (ABSK021), which has the best in class potential globally and is the first of its kind in China, had obtained clinical approval from the US FDA. ABSK021 has the potential for multi indication development, with the most promising TGCT indication being approved by the Chinese CDE and the US FDA in October 2022 and March 2023, respectively. It has the potential to become the first of its kind in China and the best of its kind globally. On November 12th, the Company announced that its key phase 3 study on the treatment of tenosynovitis giant cell tumor (TGCT) patients with Maneuver using pimitinib has achieved cumulative results, and plans to initiate market application in 2025, with commercial returns accelerating. The Company submitted an IND for the treatment of achondroplasia (ACH) with ABSK061 at the end of 2024 in China, and is expected to conduct Phase 1 clinical research on ACH in 2025, with broad market potential in the future.
Strategy：
Buy-in Price: $10.04, Target Price: $11.86, Cut Loss Price: $9.10

Shuanghuan Driveline(002472.CH) - Accelerated Overseas Expansion and Diversified Product Portfolio Advance in Tandem

Company profile:

Shuanghuan Driveline specializes in the manufacturing of gear transmission products, with the gear business accounting for about 80% of the Company's total business. The Company has gradually shifted from traditional gear products to high-precision gears and parts. Its main products span gear products (gears for passenger vehicles, commercial vehicles, engineering machinery, motorcycles and electric tools), reducers and other products, which are mainly applied in the electric drive systems, gearboxes and axles of vehicles, as well as electric tools, rail transit, wind power, industrial robots and other sectors. The Company operates five production bases in Zhejiang, Jiangsu, Chongqing, Dalian and other places.

Investment Summary

Strong Performance in New Energy Business Drives Rapid Net Profit Growth

In 2024, the Company recorded revenue of RMB8,781 million (RMB, the same below), up 8.76% yoy; net profit attributable to the parent company amounted to RMB1,024 million, up 25.42% yoy; net profit attributable to the parent company excluding non-recurring items was RMB1,001 million, up 24.64% yoy. EPS was RMB1.22, with a dividend per share of RMB0.226, representing a dividend payout ratio of 18.5%.

In Q1 2025, the Company reported revenue of RMB2,065 million, down 0.47% yoy, mainly due to the contraction of the steel trading business. Excluding this impact, core business revenue grew 12.5% yoy; net profit attributable to the parent company reached RMB276 million, up 24.70% yoy; and net profit attributable to the parent company excluding non-recurring items was RMB269 million, up 28.27% yoy.

Among the various business segments, the new energy vehicle (NEV) gear business delivered standout performance. In 2024, this segment generated revenue of RMB3.37 billion, accounting for 38.38% of the Company's total revenue, up 51.21% yoy, showing a strong upward trend. In Q1 2025, this segment continued to grow at a pace exceeding that of downstream NEV sales, further increasing its share of total revenue and becoming a key driver of performance growth.

The traditional internal combustion engine (ICE) vehicle gear segment recorded revenue of RMB1,954 million in 2024, down 1.99% yoy. In Q1 2025, this segment remained stable, with a yoy decline of approximately 5%.

The intelligent actuator segment posted revenue growth of over 69% yoy in 2024 and maintained a similar growth rate in Q1 2025.

The commercial vehicle gear segment saw a revenue decline of 18.01% yoy in 2024, mainly due to a significant yoy decrease in H2 2023. However, Q1 2025 revenue data suggests a gradual recovery from the bottom, with revenue surpassing that of Q3 and Q4 2024, although still down on a yoy basis. The Company is intensifying efforts to expand its presence in the commercial vehicle market by actively targeting leading overseas clients and strategically investing in NEV e-drive gear products for commercial vehicles.

The construction machinery gear segment remained stable across all quarters of 2024 and Q1 2025, with revenue in Q1 2025 performing slightly better than that in Q3 and Q4 2024.

Improved Sales Structure Significantly Boosts Gross and Net Margins

The Company's gross margin increased from 22.24% in 2023 to 25.01% in 2024, up 2.8ppts yoy. In Q1 2025, gross margin further rose to 26.82%, up 4.17ppts yoy. This improvement was mainly due to a reduced share of low-margin steel trading and the scale effects of high value-added passenger vehicle gear business.

The Company maintained effective cost control and stable expense ratios: the period expense ratio stood at 10.59% in 2024, up 0.3ppt yoy, with selling/administration/R&D/financial expense ratios at 0.98%/3.99%/5.19%/0.43%, respectively, representing yoy changes of -0.03/-0.08/+0.44ppts/flat. In Q1 2025, the respective ratios were 1.0%/3.8%/5.4%/0.4%, up 0.06/0.1/0.6/-0.03ppts yoy, benefiting from ongoing cost reduction and efficiency enhancement measures, as well as scale effects. The Company will continue to implement such initiatives in the coming years, including smart manufacturing and big data systems. The rise in R&D expense ratio reflects sustained investment in innovation.

The Company's net profit margin reached 11.66% in 2024, up 1.55ppts yoy; and rose further to 13.37% in Q1 2025, up 2.7ppts yoy, indicating continued improvement in profitability.

Accelerated Overseas Expansion and Diversified Product Portfolio Advance in Tandem

In the high-profile NEV gear field, the Company had established an annual production capacity of 6,500 thousand sets for NEV transmission gear shafts by the end of 2024, with full capacity utilisation. The production base for NEV transmission components in Hungary is currently in the equipment commissioning phase, with capacity to be gradually released based on existing orders. As construction of the Hungary plant progresses, delivery lead times and logistics costs will be reduced, laying a solid foundation for further global market expansion.

Centred on gear technology, the Company continues to advance its diversified product layout. Looking ahead to the next two to three years, development across business segments includes: first, driven by growing sales of domestic B-class and above models, demand for high-precision, low-noise gear products is surging. As a leading player in China's NEV gear market, the Company is expected to further increase its market share by leveraging its technological advantages and optimising its sales structure. Additionally, the coaxial reducer gear (used in industrial robots) and intelligent actuator (used in robotic vacuum cleaners) segments offer vast market potential and are likely to become new growth drivers. Other segments, including commercial vehicles and construction machinery, are expected to remain generally stable over the next two years..

Investment Thesis

Shuanghuan Driveline is a pacesetter in the domestic automotive gear industry and robotic RV reducer industry. By leveraging its advantages in capacity, management, R&D and customer base, the Company has seized the opportunities for upgrading brought by gear outsourcing and high industry barriers as a result of the booming new energy vehicle industry. Looking forward, the Company is expected to continuously benefit from the boom of new energy passenger vehicles, expansion of the industrial chains of automatic gearboxes of commercial vehicles, and rapid development of robotic reducers and gears for daily use.

As for valuation, we expected diluted EPS of the Company to RMB 1.48/1.72/2.07 of 2025/2026/2027. And we accordingly gave the target price to RMB35 respectively 24/20/17x P/E for 2025/2026/2027. "Accumulate" rating. (Closing price as at 24 June)

Risk

Progress of new production line is below expectations

Electric vehicle sales fall short of expectations

Macroeconomic downturn affects product demand

Sharply rising raw material prices or sharply falling product prices

Financials

Click Here for PDF format...

Recommendation on 27-6-2025
Recommendation	Accumulate
Price on Recommendation Date	$ 31.270
Suggested purchase price	N/A
Target Price	$ 35.000

Writer Info

Zhang Jing
(Research Analyst)

Tel: (+86 21 51699400-103)

Email:
zhangjing@phillip.com.cn

Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the “Group”) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products’ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.